These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 9639410)

  • 21. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
    Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.
    Zhang S; Endo S; Koga H; Ichikawa T; Feng X; Onda K; Washiyama K; Kumanishi T
    Jpn J Cancer Res; 1996 Sep; 87(9):900-7. PubMed ID: 8878451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.
    Kulkarni MS; Daggett JL; Bender TP; Kuehl WM; Bergsagel PL; Williams ME
    Leukemia; 2002 Jan; 16(1):127-34. PubMed ID: 11840272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines.
    Tanaka H; Shimada Y; Imamura M; Shibagaki I; Ishizaki K
    Int J Cancer; 1997 Feb; 70(4):437-42. PubMed ID: 9033652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
    Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
    Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
    Zhou M; Gu L; Yeager AM; Findley HW
    Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.
    Hirai H; Ogawa S; Hangaishi A; Takahashi T; Kurokawa M; Mitani K; Ueda R; Yazaki Y
    Leukemia; 1997 Apr; 11 Suppl 3():358-60. PubMed ID: 9209389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster.
    Aguiar RC; Sill H; Goldman JM; Cross NC
    Leukemia; 1997 Feb; 11(2):233-8. PubMed ID: 9009086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
    Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
    Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent hypermethylation of p16 and p15 genes in multiple myeloma.
    Ng MH; Chung YF; Lo KW; Wickham NW; Lee JC; Huang DP
    Blood; 1997 Apr; 89(7):2500-6. PubMed ID: 9116295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia.
    Yamada Y; Hatta Y; Murata K; Sugawara K; Ikeda S; Mine M; Maeda T; Hirakata Y; Kamihira S; Tsukasaki K; Ogawa S; Hirai H; Koeffler HP; Tomonaga M
    J Clin Oncol; 1997 May; 15(5):1778-85. PubMed ID: 9164185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
    Hangaishi A; Ogawa S; Imamura N; Miyawaki S; Miura Y; Uike N; Shimazaki C; Emi N; Takeyama K; Hirosawa S; Kamada N; Kobayashi Y; Takemoto Y; Kitani T; Toyama K; Ohtake S; Yazaki Y; Ueda R; Hirai H
    Blood; 1996 Jun; 87(12):4949-58. PubMed ID: 8652807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance.
    Diccianni MB; Chau LS; Batova A; Vu TQ; Yu AL
    Cancer Lett; 1996 Jul; 104(2):183-92. PubMed ID: 8665486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas.
    Martinez-Delgado B; Robledo M; Arranz E; Osorio A; García MJ; Echezarreta G; Rivas C; Benitez J
    Leukemia; 1998 Jun; 12(6):937-41. PubMed ID: 9639423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.